About the Osteochondroma Session
Osteochondroma, a benign bone tumor, has garnered recent attention in cancer research due to its potential for malignant transformation. While typically non-cancerous, osteochondromas possess a small risk of evolving into chondrosarcomas, a type of bone cancer. Researchers are delving into the genetic and molecular mechanisms underlying this transformation, aiming to identify predictive markers and therapeutic targets. Advanced imaging techniques and molecular profiling enable early detection of malignant progression, facilitating timely intervention. Moreover, studies explore the tumor microenvironment and its role in fostering malignant transformation, offering insights into novel treatment strategies. By elucidating the complexities of osteochondroma progression, ongoing research endeavors strive to improve diagnostic accuracy, refine risk stratification, and ultimately enhance patient outcomes in the realm of bone cancer.
Topics Covered in Osteochondroma
Hereditary Multiple Exostoses
Exostosin Gene Mutations
Cartilage Cap Thickness
Secondary Chondrosarcoma
Skeletal Deformity
Surgical Excision
Related Scientific Sessions at CIOC 2027
Why Attend the Osteochondroma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Osteochondroma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Osteochondroma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Osteochondroma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Osteochondroma Conference 2027 — FAQs
What is the Osteochondroma track at CIOC 2027?
The Osteochondroma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Osteochondroma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Osteochondroma sessions?
Cancer researchers and clinicians, educators and students with an interest in Osteochondroma are all welcome — whether presenting or attending.
Can I present my research in the Osteochondroma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Osteochondroma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Osteochondroma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.